Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Latest Posted July 27, 2021
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.
Recalled Miss Slim capsules (see product photos) were promoted for weight loss and sold online at missslimusa.com. They can be identified by the following:
- Miss Slim 10-count pack of capsules, UPC 742137605030
- Miss Slim 30-count pack of capsules, UPC 609728434472
For more information, use the link below.
HIS Issues Voluntary Nationwide Recall of Miss Slim Due to the Presence of Undeclared Sibutramine
See related recalls and warnings:
Prescription Drugs Found in Four Weight Loss Supplements
Weight Loss Supplements Contain Hidden Drugs, FDA Warns
Eleven Weight Loss Supplements Contain Undeclared Drugs, FDA Warns
For information about reporting serious reactions and problems with medical products to the U.S. Food and Drug Administration through its MedWatch reporting program, please visit the FDA MedWatch website.